0001062993-16-009883.txt : 20160519
0001062993-16-009883.hdr.sgml : 20160519
20160519114216
ACCESSION NUMBER: 0001062993-16-009883
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160518
FILED AS OF DATE: 20160519
DATE AS OF CHANGE: 20160519
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wegman Toby
CENTRAL INDEX KEY: 0001405128
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 161662351
MAIL ADDRESS:
STREET 1: 4092 BOCAIRE BLVD.
CITY: BOCA RATON
STATE: FL
ZIP: 33487
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2016-05-18
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001405128
Wegman Toby
C/O BIOSPECIFICS TECHNOLOGIES CORP.,
35 WILBUR STREET
LYNBROOK
NY
11563
1
0
0
0
Common Stock, $0.001 par value
2016-05-18
4
S
0
50
33.8
D
1005128
I
See footnote
Common Stock, $0.001 par value
2016-05-18
4
S
0
150
34.14
D
1004978
I
See footnote
Common Stock, $0.001 par value
2016-05-18
4
S
0
50
34.11
D
1004928
I
See footnote
Common Stock, $0.001 par value
2016-05-18
4
S
0
24750
33
D
980178
I
See footnote
The selling price of $33.80 is reflective of the sale price of all transactions reported on this line.
The selling price of $34.14 is reflective of the sale price of all transactions reported on this line.
The selling price of $34.11 is reflective of the sale price of all transactions reported on this line.
The selling price of $33.00 is reflective of the sale price of all transactions reported on this line.
These shares are held in trust on behalf of the reporting person and Mr. Thomas Wegman. The reporting person is the co-trustee of the trust with Mr. Thomas Wegman. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.
/s/ Carl A. Valenstein, attorney-in-fact for Thomas Wegman
2016-05-19